Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Sanofi buys haemophilia specialist for $11.6 bn

Monday, January 22, 2018 - 01:31

Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion. As Silvia Antonioli reports, the French healthcare group says the deal will boost earnings and strengthen its presence in treatments for rare diseases.

▲ Hide Transcript

View Transcript

Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion. As Silvia Antonioli reports, the French healthcare group says the deal will boost earnings and strengthen its presence in treatments for rare diseases.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Sanofi buys haemophilia specialist for $11.6 bn

Monday, January 22, 2018 - 01:31